Kathleen P. Bloch, Chief Financial Officer at Cytosorbents Corp (CTSO), sold 120 shares at $8.25 ($990) on 2018-04-17, disclosed to the SEC on 2018-04-18.
Scheduled sale ($990) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CTSO | BUY | 2023-05-12 | $31K | — | Filing → |
| CTSO | BUY | 2022-06-06 | $17K | — | Filing → |
| CTSO | BUY | 2021-11-26 | $20K | — | Filing → |